ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DBVT vs AURA // EV/EBITDA & P/E VALUATION

DBV Technologies S.A. (NASDAQ) VS. Aura Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: DBVT 1 — AURA 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DBVT VS. AURA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DBVT AURA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -18.81% -13.05% -5.76 AURA /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 35.80% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.37 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 DBVT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.7 42.6 -2.95 AURA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $647.0M $652.8M -$5.8M AURA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DBVT REV AURA REV DBVT GROSS % AURA GROSS % DBVT FCF AURA FCF
FY 2025 $5.6M $0 — — -$121.7M -$85.2M
FY 2024 $4.2M $0 — — -$106.8M -$81.1M
FY 2023 $15.7M $0 — — -$79.7M -$63.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DBVT // BETA —
AURA // BETA —